Novartis AG

NYSE: NVS
Share price (3/28/25): $112.57
Market cap (3/28/25): $222 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 12/31/23 FY 2023

ended 12/31/22 FY 2022 – amended

ended 12/31/22 FY 2022

ended 12/31/21 FY 2021 – amended

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Free writing prospectus

Prospectus supplement for primary offering

Automatic shelf registration

Third party tender offer – amended

Ownership Filter

Kowalski Robert William

News Filter

FDA Approves Novartis Radioligand Therapy Pluvicto® for Earlier Use Before Chemotherapy in PSMA-positive Metastatic Castration-Resistant Prostate Cancer

Pursuant to the Requirements of the Securities Exchange Act of 1934, the Registrant Has Duly Caused This Report to Be Signed on Its Behalf by the Undersigned, Thereunto Duly Authorized

Continues Strong Momentum of Sales Growth With Margin Expansion, Reaches Key Innovation Milestones in 2024

Intrathecal Onasemnogene Abeparvovec Phase III Study Meets Primary Endpoint in Children and Young Adults With SMA

Upgrades Mid-Term Guidance and Highlights Deep Pipeline in Core Therapeutic Areas to Drive Long-Term Growth

Proxies Filter

Proxy materials by non-management

Proxy materials by non-management

Proxy materials by non-management

Proxy materials by non-management

Proxy materials by non-management

Other Filter

Notice required by Iran Threat Reduction and Syria Human Rights Act of 2012

Conflict Minerals disclosure

Notice required by Iran Threat Reduction and Syria Human Rights Act of 2012

Conflict Minerals disclosure

Letter from the SEC